Thalidomide for the Treatment of Primary Sclerosing Cholangitis (PSC)

NCT00953615 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Lack of enrollment

Conditions

Primary Sclerosing Cholangitis

Interventions

DRUG: Thalidomide

Sponsor

Mayo Clinic

Collaborators

[object Object]